Security Snapshot

Scilex Holding Co - Common Stock, $0.0001 par value per share (SCLX) Institutional Ownership

CUSIP: 80880W205

13F Institutional Holders and Ownership History from Q2 2024 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

70

Shares (Excl. Options)

702.61KFull value: 702,606 · shares · 30 Jun 2026

Price

$7.80

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-169,113
Value change
-$943,531
Number of holders
70
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
263,415,596
SEC-reported price per share
$2.88
Insider filing price
$2.88
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • SCLX - Scilex Holding Co - Common Stock, $0.0001 par value per share is tracked under CUSIP 80880W205.
  • 70 institutions reported positions in Q2 2026.
  • 3 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 69 to 70 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $5.81MFull value: $5,805,880 · USD · 31 Mar 2026
    to
    $5.48MFull value: $5,480,420 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 70 institutions filings for Q2 2026.

Open SEC evidence

Security key

80880W205

13F reference period

Q2 2026

13F holders

70

13D/G owners

3

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
3
Security
SCLX
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SCLX Stock Acquisition JV LLC 11% $234,280,198 30,029,378 SCLX Stock Acquisition JV LLC 03 Jul 2026
ARMISTICE CAPITAL, LLC 8.6% $31,008,000 4,800,000 Armistice Capital, LLC 30 Jun 2025
ORAMED PHARMACEUTICALS INC. 4.9% -50% $5,438,249 -$4,921,820 437,510 -48% Oramed Pharmaceuticals Inc. 31 Dec 2025
As of 30 Jun 2026, 70 institutional investors reported holding
702.61KFull value: 702,606 · shares · 30 Jun 2026
shares of Scilex Holding Co - Common Stock, $0.0001 par value per share (SCLX). This represents 0.27% of the company’s total
263.42MFull value: 263,415,596 · shares · Stored outstanding share count
outstanding shares.

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
10
Headline period
Q2 2026
Rows shown
1-10 of 10
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 27,349 $120,753 +$23,268 $4.45 20
2026 Q2 702,606 $5,480,420 -$943,531 $7.80 70
2026 Q1 871,717 $5,805,880 -$2,086,274 $6.66 69
2025 Q4 1,119,739 $13,661,197 +$3,630,948 $12.20 78
2025 Q3 759,753 $14,960,373 +$3,238,244 $19.68 79
2025 Q2 619,696 $3,649,745 +$3,564,555 $5.89 63
2025 Q1 42,004 $10,442 +$10,434 $0.25 4
2024 Q4 19 $8 $0.42 1
2024 Q3 19 $18 $0.95 1
2024 Q2 19 $37 +$37 $1.95 1
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .